Pressmeddelande

Respiratorius CEO to BioStock: “We continue to reduce risk in the project”

Cision Publicerad: 15 Nov 08:15

The partnering process continues for Respiratorius, which recently released the report for the third quarter. The US patent has been approved and the focus is now on refining the VAL001 project, with a particular focus on the regulatory aspects.

– We have a clear strategy to clarify and strengthen the company’s values as well as a clear regulatory strategy, says Johan Drott to BioStock.

Read the full article at biostock.se:

https://www.biostock.se/en/2024/11/respiratorius-ceo-we-continue-to-reduce-risk-in-the-project/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Nyheter om Respiratorius

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!